Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | SCP2 | P22307 | 1/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.47 |
| ▸ | PTPRA | P18433 | 1/20 | 0.46 |
| ▸ | PTPRB | P23467 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | GLA | P06280 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | CASP1 | P29466 | 3/20 | 0.43 |
| ▸ | CASP7 | P55210 | 3/20 | 0.43 |
| ▸ | BRCA1 | P38398 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nile Red SCHEMBL49047 | 1.00 | MEN1 (1.00) | MEN1KMT2ANPC1POLBRAB9A | |
| Nile Red SCHEMBL28703996 | 0.97 | MEN1 (0.93) | MEN1KMT2ANPC1POLBRAB9A | |
| SCHEMBL7815341 | 0.89 | MEN1 (0.79) | MEN1KMT2ANPC1POLBRAB9A | |
| SCHEMBL23266942 | 0.88 | MEN1 (0.78) | MEN1KMT2ANPC1POLBRAB9A | |
| SCHEMBL15398206 | 0.88 | MEN1 (0.78) | MEN1KMT2ANPC1POLBRAB9A | |
| SCHEMBL15398222 | 0.88 | MEN1 (0.78) | MEN1KMT2ANPC1POLBRAB9A | |
| Nile Blue SCHEMBL12393690 | 0.87 | MEN1 (0.77) | MEN1KMT2ANPC1POLBRAB9A | |
| Nile Blue SCHEMBL29356294 | 0.87 | MEN1 (0.77) | MEN1KMT2ANPC1POLBRAB9A | |
| SCHEMBL8858355 | 0.86 | NPC1 (0.76) | MEN1KMT2ANPC1POLBRAB9A | |
| SCHEMBL56792 | 0.86 | MEN1 (0.76) | MEN1KMT2ANPC1POLBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616656-B2 | Adventitial painting modality of local drug delivery to abate intimal hyperplasia | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2026-05-05 | — | — | US | claimed |
| EP-3929585-B1 | A METHOD AND A BIOSENSING DEVICE FOR PEPTIDES AND PROTEINS DETECTION AND QUANTIFICATION | INST SUPERIOR DE ENGENHARIA DO PORTO (PT) | 2024-12-25 | — | — | EP | claimed |
| US-20240238198-A1 | AN ADVENTITIAL PAINTING MODALITY OF LOCAL DRUG DELIVERY TO ABATE INTIMAL HYPERPLASIA | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2024-07-18 | — | — | US | claimed |
| EP-3740585-B1 | IMPROVING DETECTION OF MICROORGANISMS | BACTOBYTE LTD (IL) | 2023-09-27 | — | — | EP | claimed |
| CN-116274188-A | Device for purging UHP device and purging method thereof | 镇江微笙科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| WO-2022246462-A1 | AN ADVENTITIAL PAINTING MODALITY OF LOCAL DRUG DELIVERY TO ABATE INTIMAL HYPERPLASIA | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-11-24 | — | — | WO | claimed |
| US-20260144740-A1 | COSMETIC ACTIVE INGREDIENT DERIVED FROM A NON-VOLATILE FRACTION OF CANARIUM EXUDATE AND USES THEREOF | FLORE SCOLA (FR) | 2026-05-28 | — | — | US | disclosed |
| CN-122037594-A | Polymethyl methacrylate nanoparticle compounded Pickering emulsified asphalt and preparation method thereof | 太原理工大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20260126387-A1 | IN-SITU DETECTION METHOD FOR REACTIVE OXYGEN SPECIES BASED ON RATIOMETRIC FLUORESCENT PROBE | NANJING UNIVERSITY (CN) | 2026-05-07 | — | — | US | disclosed |
| US-12616656-B2 | Adventitial painting modality of local drug delivery to abate intimal hyperplasia | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2026-05-05 | — | — | US | disclosed |
| US-12612384-B2 | Heterocyclic CYP4A inhibitor compounds and compositions thereof | MBD Co., Ltd. (KR) | 2026-04-28 | — | — | US | disclosed |
| US-20260108503-A1 | POLYMERIC MICELLE NANOCARRIERS FOR TARGETED EPIDERMAL DELIVERY OF THE HEDGEHOG PATHWAY INHIBITOR TAK-441 | UNIV DE GENE DE GENEVE (CH) | 2026-04-23 | — | — | US | disclosed |
| US-12594310-B2 | Composition comprising lactic acid bacteria derived from green tea for improving liver function | AMOREPACIFIC CORPORATION (KR) | 2026-04-07 | — | — | US | disclosed |
| US-11324823-B2 | Biophotonic materials and uses thereof | KLOX TECHNOLOGIES INC. (CA) | 2022-05-10 | — | — | US | disclosed |
| WO-2022092338-A1 | METHOD FOR INCREASING METABOLIC PRODUCTIVITY OF MICROORGANISMS USING C1 GAS BY USING ORGANIC MATERIAL-BASED NANOFLUID | 충남대학교산학협력단 | 2022-05-05 | — | — | WO | disclosed |
| WO-2022091822-A1 | METHOD FOR FREEZING CELL STRUCTURE | 国立大学法人大阪大学 | 2022-05-05 | — | — | WO | disclosed |
| WO-2022055929-A1 | POLYVALENT STING ACTIVATING COMPOSITIONS AND USES THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-03-17 | — | — | WO | disclosed |
| US-20220071903-A1 | POLYVALENT STING ACTIVATING COMPOSITIONS AND USES THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-03-10 | — | — | US | disclosed |
| EP-3964511-A1 | BIOORTHOGONAL CHOLESTEROL PROBE AND USES THEREOF | Universidad del País Vasco/Euskal Herriko Unibertsitatea (ES) | 2022-03-09 | — | — | EP | disclosed |
| US-20220031849-A1 | NANOPARTICLE ENCAPSULATION TO TARGET G PROTEIN-COUPLED RECEPTORS IN ENDOSOMES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594310-B2 | Composition comprising lactic acid bacteria derived from green tea for improving liver function | LIPC, FABP1, FABP2 | MEN1 4879/4885KMT2A 3805/4885NPC1 3222/4885 |
| US-12612384-B2 | Heterocyclic CYP4A inhibitor compounds and compositions thereof | CYP4A11, CYP4B1, CYP4A22 | MEN1 4640/4885KMT2A 2591/4885NPC1 154/4885 |
| US-20220071903-A1 | POLYVALENT STING ACTIVATING COMPOSITIONS AND USES THEREOF | STING1, CGAS, TLR7 | MEN1 539/4885KMT2A 3087/4885NPC1 2734/4885 |
| US-20260108503-A1 | POLYMERIC MICELLE NANOCARRIERS FOR TARGETED EPIDERMAL DELIVERY OF THE HEDGEHOG PATHWAY INHIBITOR TAK-441 | SHH, SMO, GLI1 | MEN1 3189/4885KMT2A 1375/4885NPC1 2789/4885 |
| US-20220031849-A1 | NANOPARTICLE ENCAPSULATION TO TARGET G PROTEIN-COUPLED RECEPTORS IN ENDOSOMES | GPR88, GPR65, ARRB1 | MEN1 3215/4885KMT2A 3428/4885NPC1 109/4885 |
| US-20260144740-A1 | COSMETIC ACTIVE INGREDIENT DERIVED FROM A NON-VOLATILE FRACTION OF CANARIUM EXUDATE AND USES THEREOF | NOTUM, CUTA, ALOX15 | MEN1 3961/4885KMT2A 4741/4885NPC1 434/4885 |
| US-20260126387-A1 | IN-SITU DETECTION METHOD FOR REACTIVE OXYGEN SPECIES BASED ON RATIOMETRIC FLUORESCENT PROBE | CYBA, NOX4, IK | MEN1 4803/4885KMT2A 4636/4885NPC1 749/4885 |
| US-12616656-B2 | Adventitial painting modality of local drug delivery to abate intimal hyperplasia | ADRA1B, ADRB1, ADRB3 | MEN1 4609/4885KMT2A 3337/4885NPC1 2389/4885 |
| US-20240238198-A1 | AN ADVENTITIAL PAINTING MODALITY OF LOCAL DRUG DELIVERY TO ABATE INTIMAL HYPERPLASIA | SHMT1, PNISR, CD44 | MEN1 3600/4885KMT2A 1632/4885NPC1 4152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.